Metrovacesa Statistics
Total Valuation
Metrovacesa has a market cap or net worth of EUR 1.73 billion. The enterprise value is 2.07 billion.
| Market Cap | 1.73B |
| Enterprise Value | 2.07B |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | Dec 19, 2025 |
Share Statistics
Metrovacesa has 151.58 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 151.58M |
| Shares Outstanding | 151.58M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.74% |
| Float | 6.95M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 34.03 |
| PS Ratio | 3.11 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 56.61 |
| P/OCF Ratio | 56.38 |
| PEG Ratio | 1.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.23, with an EV/FCF ratio of 67.75.
| EV / Earnings | -601.84 |
| EV / Sales | 3.72 |
| EV / EBITDA | 34.23 |
| EV / EBIT | 35.86 |
| EV / FCF | 67.75 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.29.
| Current Ratio | 3.34 |
| Quick Ratio | 0.27 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 7.20 |
| Debt / FCF | 14.26 |
| Interest Coverage | 2.04 |
Financial Efficiency
Return on equity (ROE) is -0.22% and return on invested capital (ROIC) is 1.80%.
| Return on Equity (ROE) | -0.22% |
| Return on Assets (ROA) | 1.46% |
| Return on Invested Capital (ROIC) | 1.80% |
| Return on Capital Employed (ROCE) | 3.19% |
| Revenue Per Employee | 2.58M |
| Profits Per Employee | -15,981 |
| Employee Count | 218 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.24 |
Taxes
In the past 12 months, Metrovacesa has paid 5.51 million in taxes.
| Income Tax | 5.51M |
| Effective Tax Rate | 265.91% |
Stock Price Statistics
The stock price has increased by +31.27% in the last 52 weeks. The beta is 0.53, so Metrovacesa's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +31.27% |
| 50-Day Moving Average | 10.74 |
| 200-Day Moving Average | 10.43 |
| Relative Strength Index (RSI) | 50.96 |
| Average Volume (20 Days) | 127,569 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Metrovacesa had revenue of EUR 555.25 million and -3.44 million in losses. Loss per share was -0.02.
| Revenue | 555.25M |
| Gross Profit | 107.31M |
| Operating Income | 57.67M |
| Pretax Income | 2.07M |
| Net Income | -3.44M |
| EBITDA | 60.42M |
| EBIT | 57.67M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 95.17 million in cash and 435.13 million in debt, giving a net cash position of -339.96 million or -2.24 per share.
| Cash & Cash Equivalents | 95.17M |
| Total Debt | 435.13M |
| Net Cash | -339.96M |
| Net Cash Per Share | -2.24 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 9.97 |
| Working Capital | 1.42B |
Cash Flow
In the last 12 months, operating cash flow was 30.65 million and capital expenditures -123,000, giving a free cash flow of 30.52 million.
| Operating Cash Flow | 30.65M |
| Capital Expenditures | -123,000 |
| Free Cash Flow | 30.52M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 19.33%, with operating and profit margins of 10.39% and -0.62%.
| Gross Margin | 19.33% |
| Operating Margin | 10.39% |
| Pretax Margin | 0.37% |
| Profit Margin | -0.62% |
| EBITDA Margin | 10.88% |
| EBIT Margin | 10.39% |
| FCF Margin | 5.50% |
Dividends & Yields
This stock pays an annual dividend of 0.79, which amounts to a dividend yield of 6.93%.
| Dividend Per Share | 0.79 |
| Dividend Yield | 6.93% |
| Dividend Growth (YoY) | 128.99% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 6.90% |
| Earnings Yield | -0.20% |
| FCF Yield | 1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |